GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: majormember who wrote (8)	1/28/1999 1:10:00 PM
From: Street Walker	Read Replies (2) of 5582

From yahoo msg board post.messages.yahoo.com@m2.yahoo.com Also, gunn allen price target is the exact same target they had even before the product was even known. It is a reiteration of a current price target. If Zicam only treats 1% of all the commmon colds in the US this year, The stock will be between $45 - $60, and thats just based on the Zicam product alone. When they start selling internationally and obtain a greater percentage of the Cold Market, it will go $100+. A few years, this stock could be as high as $300 as they enter the World Market. Can anyone verify the following -- how much GUMM makes per sale? messages.yahoo.com@m2.yahoo.com Regards, S.W.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next